Task: Answer the multiple-choice question.
Query: Which drug exhibits a 4.809% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a COc1ccc(S(=O)(=O)Nc2ccccc2C)cc1
b COC(=O)c1ccccc1NC(=O)Nc1nnc(N2CCC(C)CC2)s1
Answer: b. COC(=O)c1ccccc1NC(=O)Nc1nnc(N2CCC(C)CC2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccccc1NC(=O)Nc1nnc(N2CCC(C)CC2)s1
COC(=O)c1ccccc1NC(=O)Nc1nnc(N2CCC(C)CC2)s1
methyl 2-[[5-(4-methylpiperidin-1-yl)-1,3,4-thiadiazol-2-yl]carbamoylamino]benzoate